Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh

被引:8
|
作者
Amin, Mohammad Nurul [1 ]
Khan, Tahir Mehmood [2 ]
Dewan, Syed Masudur Rahman [1 ]
Islam, Mohammad Safiqul [1 ]
Moghal, Mizanur Rahman [1 ]
Ming, Long Chiau [3 ,4 ]
机构
[1] Noakhali Sci & Technol Univ, Dept Pharm, Noakhali, Bangladesh
[2] Monash Univ Malaysia, Sch Pharm, Selangor, Malaysia
[3] Univ Tasmania, Sch Med, UMORE, Pharm, Hobart, Tas, Australia
[4] Univ Teknol MARA UiTM, Fac Pharm, Vector Borne Dis Res Grp VERDI, Puncak Alam, Malaysia
来源
BMJ OPEN | 2016年 / 6卷 / 08期
关键词
SAUDI-ARABIA; VALIDATION;
D O I
10.1136/bmjopen-2015-010912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To assess community pharmacists'/pharmacy technicians' knowledge and perceptions about adverse drug reactions (ADRs) and barriers towards the reporting of such reactions in Dhaka, Bangladesh. Method: A cross-sectional study was planned to approach potential respondents for the study. A self-administered questionnaire was delivered to community pharmacists/pharmacy technicians (N=292) practising in Dhaka, Bangladesh. Results: The overall response to the survey was 69.5% (n=203). The majority of the sample was comprised of pharmacy technicians (152, 74.9%) who possessed a diploma in pharmacy, followed by pharmacists (37, 18.2%) and others (12, 5.9%). Overall, 72 (35.5%) of the respondents disclosed that they had experienced an ADR at their pharmacy, yet more than half (105, 51.7%) were not familiar with the existence of an ADR reporting body in Bangladesh. Exploring the barriers to the reporting of ADRs, it was revealed that the top four barriers to ADR reporting were 'I do not know how to report (Relative Importance Index (RII)=0.998)', 'reporting forms are not available (0.996)', 'I am not motivated to report (0.997)' and 'Unavailability of professional environment to discuss about ADR (RII=0.939)'. In addition to these, a majority (141, 69.46%) were not confident about the classification of ADRs (RII=0.889) and were afraid of legal liabilities associated with reporting ADRs (RII=0.806). Moreover, a lack of knowledge about pharmacotherapy and the detection of ADRs was another major factor hindering their reporting (RII=0.731). Conclusions: The Directorate of Drug Administration in Bangladesh needs to consider the results of this study to help it improve and simplify ADR reporting in Bangladeshi community pharmacy settings.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] SPONTANEOUS REPORTING OF ADVERSE DRUG REACTIONS IN COMMUNITY PHARMACY
    Yu, Y. M.
    Koo, B.
    Jeong, K.
    Choi, K. H.
    Kang, L.
    Oh, J. M.
    Shin, W. G.
    Lee, E.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A289 - A289
  • [2] Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
    Li, Raymond
    Curtain, Colin
    Bereznicki, Luke
    Zaidi, Syed Tabish Razi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (04) : 878 - 889
  • [3] Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
    Raymond Li
    Colin Curtain
    Luke Bereznicki
    Syed Tabish Razi Zaidi
    [J]. International Journal of Clinical Pharmacy, 2018, 40 : 878 - 889
  • [4] An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China
    Zhao, Zhigang
    Shen, Jiashu
    Shen, Chuanyong
    Zhu, Bin
    Sun, Jun
    Yu, Jinyang
    Sun, Feng
    Song, Haibo
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (11) : 2001 - 2006
  • [5] Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study
    Kusturica, Milica Paut
    Tomas, Ana
    Raskovic, Aleksandar
    Gigov, Slobodan
    Crnobrnja, Veljko
    Jevtic, Marija
    Stilinovic, Nebojsa
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (07) : 1229 - 1236
  • [6] Barriers to reporting of adverse drugs reactions: A cross sectional study among community pharmacists in Indian locality
    Srikanth, M. S.
    Adepu, Ramesh
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 513 - 513
  • [7] Reporting suspected adverse drug reactions in Celje community pharmacy
    Glavnik, Teja
    Kovacic, Alenka
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (02) : 604 - 605
  • [8] Adverse drug events in hospital settings: Reporting & fate at a tertiary academic hospital: Cross-sectional study
    Almetwazi, Mansour
    Alqasem, Mohammed
    AlHadlaq, Tariq
    Aljumayd, Ali
    Alreshedi, Faisal
    Mancy, Wael
    Alqahtani, Nasser
    Alhuwyail, Ghadah
    Alhawassi, Tariq
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 254 - 255
  • [9] A qualitative study exploring barriers and facilitators for reporting of adverse drug reactions (ADRs) among community pharmacists in Malaysia
    Elkalmi, Ramadan Mohamed
    Hassali, Mohamed Azmi
    Ibrahim, Mohamed Izham M.
    Liau, Siow Yen
    Awaisu, Ahmed
    [J]. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2011, 2 (02) : 71 - 78
  • [10] Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study
    Hussain, Saad Abdulrahman
    Abbas, Ashwaq Nagemeldeen
    Habeeb, Shah-Zanan Alaa
    Abd-Ali, Athraa Kareem
    Abdulrahman, Zainab Saad
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (05) : 1307 - 1313